Physician profile
Asad Cheema
NPI 1639171457
$26,639.86
in general payments reported to CMS, 2019-2025
24 companies · $6,196 in 2025
The $6,196 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,599 · 2020: $2,166 · 2021: $2,968 · 2022: $4,160 · 2023: $3,053 · 2024: $6,497 · 2025: $6,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,668 · Travel and Lodging: $4,829 · Consulting Fee: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,668.03 |
| Travel and Lodging | $4,828.67 |
| Consulting Fee | $1,249.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,854.43 | 2019-2025 | Farapulse, Emblem Mri S-Icd, Watchman Flx |
| Biosense Webster, INC. | $7,473.76 | 2019-2025 | Carto 3, Thermocool Sf, Qdot Micro Catheter |
| Cvrx, INC. | $5,686.39 | 2020-2025 | Barostim Neo System |
| Abbott Laboratories | $2,096.91 | 2022-2025 | Gallant, Dragonfly Opstar, Jot Dx |
| Biotronik INC. | $1,405.97 | 2019-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Philips North America LLC | $375.26 | 2023-2024 | (Ao0) Igt Devices Intracardiac |
| Novartis Pharmaceuticals Corporation | $232.10 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $224.34 | 2019-2025 | Lifevest |
| Cardiva Medical, INC. | $173.27 | 2021-2023 | Cardiva Vascade 6/7f Vcs |
| Medtronic, INC. | $170.94 | 2025 | Symplicity G3 |
| Penumbra, INC. | $148.80 | 2024 | Indigo System |
| Regeneron Healthcare Solutions, INC. | $124.34 | 2019 | |
| Abiomed | $111.96 | 2020 | |
| Amgen INC. | $105.85 | 2019-2024 | Repatha |
| Cordis US Corp. | $98.08 | 2025 | Mynx Control Venous |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $82.95 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Medtronic Vascular, INC. | $77.63 | 2019 | |
| Itamar Medical INC | $49.07 | 2023 | Watchpatone |
| E.R. Squibb & Sons, L.L.C. | $39.25 | 2019 | |
| Opsens INC. | $28.68 | 2021 | |
| Janssen Pharmaceuticals, INC | $28.04 | 2020 | |
| Kestra Medical Technology Services, INC. | $22.11 | 2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $17.45 | 2019 | |
| Amarin Pharma, INC. | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asad Cheema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.